Shanghai Ruikang Biotechnology Co., Ltd. (Shanghai Ruikang Biotechnology) is a high-tech enterprise specializing in the research and development, production, and sales of medical diagnostic equipment, clinical in vitro diagnostic reagents, and related technical services. Was founded in September 2011 and is located in Pujiang High tech Park, Caohejing Development Zone, Shanghai.
We have first-class, standardized, and large-scale production plants and R&D laboratories, and have established multiple IVD reagent and instrument R&D and production subsidiaries in Shanghai, Tianjin, China, and Silicon Valley in the United States; Established a high standard quality assurance system and passed the TUV South Germany ISO13485 certification; We have a research and development, production, and management team led by Chinese and foreign PhDs.
Adhering to independent research and development, we have established a full range of biochemical reagent technology development platforms, especially the latex enhanced immunoturbidimetry research and development platform, which is leading domestically and has obtained nearly a hundred Class II biochemical reagent medical device product registration certificates; We have established a globally leading clinical mass spectrometry technology development platform, equipped with our own brand of Class II medical device product registration certificate - the ultra-high performance liquid chromatography tandem mass spectrometry detection system RZ-500, sample automation pre-processing device AUTOMAN ELITE, and more than 30 Class II and Class I clinical mass spectrometry reagents have obtained medical device product registration and filing certificates, leading the development of clinical mass spectrometry in China; We have established an international standard third-party quality control technology development platform, providing a wide coverage and stable series of quality control products.
Undertaking multiple scientific and technological innovation projects and industry university research projects supported by the Shanghai Municipal/District Science and Technology Commission and Zhangjiang Special Development Fund, multiple research and development achievements have been recognized as Shanghai's high-tech achievement transformation projects, and dozens of technologies and products have obtained national invention patent certificates; Has been recognized as a "high-tech enterprise" for several consecutive years; Has won multiple honors in Shanghai, including "Specialized, Refined, Unique and New" Enterprise, "Innovative Small and Medium sized Enterprise", "Shanghai Patent Work Pilot Enterprise", "Shanghai Science and Technology Enterprise Incubator 30-year Star Science and Technology Innovation Enterprise", "Minhang District Patent Work (Intellectual Property Education) Demonstration Unit", and "Minhang District Science and Technology Little Giant Enterprise".
We have established a clinical mass spectrometry technology research and application exploration alliance through extensive cooperation with overseas research units, well-known enterprises, leading clinical institutions and scholars in China. We are committed to solving the pain points of mass spectrometry technology clinical application, providing a comprehensive solution for clinical mass spectrometry IVD products with a complete business process of sample pretreatment instrument reagent software service, achieving compliance, standardization and automation of clinical mass spectrometry, and striving to be a leader in clinical mass spectrometry.
Adhering to the principle of "smart and innovative technology, technology cares for health", we have established a long-term, efficient, stable, and mutually beneficial business cooperation platform across the country. We are willing to work hand in hand with like-minded people who are willing to grow together with us, and with leading technological strength and professional services, we will help promote China's big health industry!
PurposeSmart, innovative, technological, and caring for health.
ValuesIntegrity、Pragmatism、Pursuing Excellence.
MissionWe respect science, innovate and develop, and provide clinical testing products that promote medical development.
VisionLeveraging advanced technology and expert services boosting China's health industry.
Founder and Chairman of Shanghai Ruikang Biotechnology, with over 30 years of experience in in vitro diagnostics (IVD). Since the establishment of the company, he has successively invested in and founded several IVD reagent and instrument R&D and manufacturing subsidiaries in China and USA. He was a pioneer in building a mass spectrometry diagnostic technology platform in the IVD field, advocating and promoting precision diagnostics, and leading the industry's development with an international perspective.
Before founding Shanghai Reigncom Biotech, he successively held key positions such as supervisor, director, and marketing general manager at Shanghai Kehua Bio-engineering Co., Ltd., managing the company's marketing and building a nationwide sales network. With continuous marketing innovation, he achieved milestone business growth, laying the key foundation for Kehua to become the first listed company in China's IVD industry.
As one of the first successful entrepreneurs in China's IVD industry, his profound professional knowledge and practical skills, far-reaching strategic vision, and passionate pursuit of technology have earned him a prestigious reputation within the industry.
The Chief Scientific Officer (CSO) of Shanghai Reigncom Biotech and the CEO of Shanghai Reach Medical Instruments, also a part-time professor at Shanghai Jiao Tong University School of Medicine, and a recipient of the Shanghai for overseas high-level talents.
With over 20 years of experience in mass spectrometry research and development, application, and market development, he led the global clinical mass spectrometry application team at Thermo Fisher Scientific in the United States, developing over 100 new methods for clinical mass spectrometry applications. He holds a Ph.D. in Biochemistry and Molecular Biology from Peking University, completed his postdoctoral studies at the University of Michigan, and attended the Stanford University Graduate School of Business. He has published over 20 papers on mass spectrometry, holds four authorized invention patents, co-edited "Clinical Applications of Liquid Chromatography-Mass Spectrometry," and authored the "Expert Consensus on Mass Spectrometry Detection of Androgens in Polycystic Ovary Syndrome."
Currently, he serves as a member of the Mass Spectrometry Group of the Medical Inspection Quality Management Professional Committee of the China Pharmaceutical Quality Management Association, a member of the Therapeutic Drug Monitoring Research Professional Committee of the Shanghai Pharmacological Society, and a member of the Mass Spectrometry Committee of CACLP.
Tel
021-60838199
Customer Service Line
400-839-8199
Fax
021-60705089
Address
Floor 3&4, 1st Building of Building 1,
NO.3279 Sanlu Road, Minhang District,
Shanghai, China（201112）
Tel : 021-60838199
Customer Service Line : 400-839-8199
Fax : 021-60705089
Address : Floor 3&4, 1st Building of Building 1, Scan Code To Follow Us
Copyright © 2025 上海睿康生物科技有限公司
版权所有 沪ICP备17039165号-1
